Ihuman Inc Stock Fundamentals
| IH Stock | USD 2.51 0.21 7.72% |
Ihuman Inc fundamentals help investors to digest information that contributes to Ihuman's financial success or failures. It also enables traders to predict the movement of Ihuman Stock. The fundamental analysis module provides a way to measure Ihuman's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ihuman stock.
As of now, Ihuman's Net Income From Continuing Ops is increasing as compared to previous years. The Ihuman's current EBIT is estimated to increase to about 193.1 M, while Interest Expense is projected to decrease to under 13.1 M.
Ihuman | Select Account or Indicator |
Ihuman Inc Company Profit Margin Analysis
Ihuman's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Ihuman Profit Margin | 0.11 % |
Most of Ihuman's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ihuman Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Ihuman Pretax Profit Margin
Pretax Profit Margin |
|
As of now, Ihuman's Pretax Profit Margin is increasing as compared to previous years.
Based on the latest financial disclosure, Ihuman Inc has a Profit Margin of 0.1121%. This is 96.3% lower than that of the Hotels, Restaurants & Leisure sector and 92.99% lower than that of the Consumer Discretionary industry. The profit margin for all United States stocks is 108.83% lower than that of the firm.
Ihuman Inc Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Ihuman's current stock value. Our valuation model uses many indicators to compare Ihuman value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ihuman competition to find correlations between indicators driving Ihuman's intrinsic value. More Info.Ihuman Inc is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers reporting about 0.31 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Ihuman Inc is roughly 3.26 . As of now, Ihuman's Return On Equity is increasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Ihuman's earnings, one of the primary drivers of an investment's value.Ihuman Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ihuman's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Ihuman could also be used in its relative valuation, which is a method of valuing Ihuman by comparing valuation metrics of similar companies.Ihuman is currently under evaluation in profit margin category among its peers.
Ihuman Current Valuation Drivers
We derive many important indicators used in calculating different scores of Ihuman from analyzing Ihuman's financial statements. These drivers represent accounts that assess Ihuman's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Ihuman's important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 25.2B | 26.8B | 4.8B | 6.1B | 7.0B | 6.7B | |
| Enterprise Value | 25.1B | 25.9B | 3.7B | 4.9B | 5.6B | 5.3B |
Ihuman ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Ihuman's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Ihuman's managers, analysts, and investors.Environmental | Governance | Social |
Ihuman Fundamentals
| Return On Equity | 0.11 | ||||
| Return On Asset | 0.0348 | ||||
| Profit Margin | 0.11 % | ||||
| Operating Margin | 0.09 % | ||||
| Current Valuation | (25.6 M) | ||||
| Shares Outstanding | 23.42 M | ||||
| Shares Owned By Institutions | 0.67 % | ||||
| Number Of Shares Shorted | 8.88 K | ||||
| Price To Earning | 7.83 X | ||||
| Price To Book | 1.06 X | ||||
| Price To Sales | 0.14 X | ||||
| Revenue | 1.02 B | ||||
| Gross Profit | 661.96 M | ||||
| EBITDA | 171.58 M | ||||
| Net Income | 180.91 M | ||||
| Cash And Equivalents | 1.05 B | ||||
| Cash Per Share | 16.08 X | ||||
| Total Debt | 3.86 M | ||||
| Debt To Equity | 0.03 % | ||||
| Current Ratio | 2.27 X | ||||
| Book Value Per Share | 17.74 X | ||||
| Cash Flow From Operations | 172.12 M | ||||
| Short Ratio | 0.09 X | ||||
| Earnings Per Share | 0.27 X | ||||
| Target Price | 3.86 | ||||
| Number Of Employees | 783 | ||||
| Beta | 0.37 | ||||
| Market Capitalization | 135.25 M | ||||
| Total Asset | 1.45 B | ||||
| Retained Earnings | (140.46 M) | ||||
| Working Capital | 891.68 M | ||||
| Annual Yield | 0.06 % | ||||
| Net Asset | 1.45 B |
About Ihuman Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ihuman Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ihuman using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ihuman Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 366.4 M | 251 M | |
| Total Revenue | 1.2 B | 702.3 M | |
| Cost Of Revenue | 341.4 M | 218.5 M | |
| Stock Based Compensation To Revenue | 0.01 | 0.01 | |
| Sales General And Administrative To Revenue | 0.12 | 0.11 | |
| Research And Ddevelopement To Revenue | 0.29 | 0.47 | |
| Capex To Revenue | 0.01 | 0.01 | |
| Revenue Per Share | 3.34 | 1.98 | |
| Ebit Per Revenue | 0.14 | 0.15 |
Currently Active Assets on Macroaxis
Check out Ihuman Piotroski F Score and Ihuman Altman Z Score analysis. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Hotels, Restaurants & Leisure space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ihuman. If investors know Ihuman will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ihuman listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.53) | Earnings Share 0.27 | Revenue Per Share | Quarterly Revenue Growth (0.08) | Return On Assets |
The market value of Ihuman Inc is measured differently than its book value, which is the value of Ihuman that is recorded on the company's balance sheet. Investors also form their own opinion of Ihuman's value that differs from its market value or its book value, called intrinsic value, which is Ihuman's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ihuman's market value can be influenced by many factors that don't directly affect Ihuman's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ihuman's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ihuman is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ihuman's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.